Chloramphenicol-resistant strains of Bacteroides fragilis (minimum inhibitory concentration, 12.5 ,tg/ml) were isolated from a stool specimen which contained multiply resistant Escherichia coli. The enzyme responsible for resistance, chloramphenicol acetyltransferase, was produced constitutively by these strains; the specific acti'vity was 10-fold lower than that of the E. coli enzymes. Similar activity was not detected in susceptible B. fragilis strains, nor could it be induced by growth in the presence of chloramphenicol or by mutagenesis. The enzyme had a pH optimum of 7.8 and a molecular weight of approximately 89,000. The Km for chloramphenicol was 5.2 ,tM, and the enzyme was sensitive to inhibition by 5,5'-dithiobis-2-nitrobenzoic acid. The enzyme produced by an E. coli strain isolated from the same specimen had a similar Km and sensitivity to 5,5'-dithiobis-2-nitrobenzoic acid.
otic susceptibility of Bacteroides fragilis have indicated that this species is uniformly susceptible to Cm; at least 90% of isolates are inhibited by 6.2 ,ug of the antibiotic per ml. A survey conducted by Bodner et al. (3) noted at least one Bacteroides (species undefined) strain resistant to 25 jig of Cm per ml, but the basis of the resistance was not investigated. There have been no other reports of Cm-resistant B. fragilis, nor has the production of CAT in this species been recorded previously. We report here the isolation of B. fragilis strains moderately resistant to Cm due to CAT production. The properties of the enzyme are described and compared with those of other CATs. The origin of genes specifying CAT production in this species is discussed.
MATERIALS AND METHODS
Bacterial strains. E. coli strain J5.3(R387) was provided by N. Datta. Plasmid R387, conferring resistance to Cm and streptomycin (9) , was transferred into a rifampin-resistant W3110 host, JP995; the CAT produced by this strain was used for reference. Other E. coli strains (MB24 to MB33) were isolated from a stool specimen on MacConkey agar containing Cm (20 ,ug/ml) or tetracycline (20 ,ug/ml) . Strains of B. fragilis were also isolated from stool specimens (see below) and identified according to procedures in the Virginia Polytechnic Institute Anaerobe Laboratory Manual (10) . All strains were stored at -21°C in glycerol storage broths (50% glycerol).
Culture conditions. B. fragilis strains were grown in anaerobic brain heart infusion (ABHI) broth (Difco Laboratories, Detroit, Mich.). Broths were prereduced in an anaerobic chamber (5) before addition of a 1% (vol/vol) inoculum from an overnight starter culture. Bottles were then sealed, removed from the chamber, and incubated at 37°C, unshaken. In some experiments, subinhibitory concentrations of Cm were added, either at inoculation or during logarithmic growth, to induce CAT. All anaerobic cultures were handled in the anaerobic chamber. E. coli strains were grown in nutrient broth at 37°C on a reciprocating shaker.
Isolation of Cm-resistant B. frlagilis strains. 10 ,ug of Cm per ml (ABHI-Cm), then incubated anaerobically for 48 h. Single colonies were purified on ABHI or ABHI-Cm plates, Gram stained, and tested for aerobic growth before storage. The gentamicin broths were also plated for aerobic growth on MacConkey agar and nutrient agar plates.
MIC determination. Minimal inhibitory concentrations (MICs) for antibiotics were determined by both agar and broth dilution techniques (20) for B. fragilis strains, using ABHI media. Single-colony MICs were determined by spotting appropriate dilutions (10-4 to 10-6) onto ABHI agar plates; the MIC was taken as the concentration that prevented singlecolony growth after 48 h of incubation. MICs for E. coli strains were estimated similarly, after 24 h of incubation on MacConkey agar plates.
Mutagenic treatment. The mutagenic treatment described by Adelberg et al. (1) was modified for use with strict anaerobes as follows. An overnight ABHI culture of B. fragilis was diluted 1 in 10 into fresh ABHI and incubated at 37°C for 2 h. The culture was centrifuged (1,500 x g, 10 min) in the anaerobic chamoer, and cells were suspended in 0.1 volume of reduced citrate buffer (0.1 M, pH 5.5, plus 0.05% cysteinehydrochloride and 0.0004% resazurin). Samples (0.5 ml) of cells were added to 4.5 ml of reduced citrate buffer containing 100 Mug of N-methyl-N'-nitro-N-nitrosoguanidine per ml and incubated at 37°C for 30 min. Suspensions were diluted 1 in 100 into ABHI broth for overnight incubation before selection for resistance to rifampin (100 ,ug/ml) and Cm (10 ug/ml).
Preparation of cell-free extracts. Cells from stationary-phase cultures (usually 250 ml) were harvested by centrifugation (7,000 x g, 20 Sensitivity to 1 to 10 mM disodium ethylenediaminetetraacetic acid and 1 mM p-chloromercuribenzoate was estimated after 5 min of preincubation with enzyme at 37°C; the UV assay was used to estimate sensitivity to p-chloromercuribenzoate.
Purification of CAT from B. fragili& Attempts were made to purify the CAT activity from B. fragilis strains using the method of Shaw and Brodsky (19) . Cell-free extracts were prepared from 21 cultures (10 to 15 g [wet weight] of cells). After the second ammonium sulfate precipitation, extracts were desalted using a Sephadex G-50 column, then applied to diethylaminoethyl-Sephadex, Sephadex G-100, or Sephadex G-200 columns.
Column chromatography. All Sephadex gels were prepared according to the manufacturer's instructions, and chromatography was performed as described by Andrews (2) . Sephadex G-100 and G-200 columns (2.5 by 90 cm) were equilibrated in TM buffer containing 0.15 M KCI, and the G-50 column (1.5 by 17 cm) was equilibrated in TM or Tris-hydrochloride (0.01 M, pH 7.8) buffers. Molecular-weight calibration of the Sephadex G-100 column was made using alkaline phosphatase, bovine serum albumin, ovalbumin, CAT activity in B. fragli& CAT activity in the Cm-resistant strains was difficult to estimate using the DTNB assay, due to relatively high levels of nonspecific thioesterase activity (detected by the formation of CoA-SH in the absence of Cm). Such thioesterase activity was found in all B. fragilis strains screened, and the levels observed for strains F47 and F48 often represented 60 to -90% of the total activity assayed. Heating cell-free extracts at 70 to 750C for 10 min (see below) caused a 90 to 95% reduction in thioesterase activity without markedly decreasing CAT activity; specific activities were determined for these heated preparations ( Table  2 ). The specific activities for CAT produced by strains F47 and F48 were more than 10-fold lower than those for the E. coli enzymes. CAT in strain F48 was constitutively produced throughout growth, with maximum activity occurring during stationary phase. Enzyme levels were not increased by growth in broths containing Cm. The enzyme was unique to the Cmresistant strains; no CAT activity occurred in sensitive isolates (MIC, -6.2 ,ug/ml), nor could any activity be induced by growth in Cm or by mutagenesis, although N-methyl-N'-nitro-N-nitrosoguanidine treatment resulted in rifampinresistant mutants at a frequency of -10'.
The products of Cm acetylation by CAT were detected using thin-layer chromatography. Four compounds were observed when Cm was incubated with acetyl CoA and cell-free extracts of JP995(R387). These correspond to unaltered (ii) pH optimum. The pH optimum was determined for an extract of strain F48 desalted on Sephadex G-50 and heated to remove nonspe- A cell-free extract of strain F48 (from 200 ml of ABHI culture) was desalted on a Sephadex G-50 column. Samples of enzyme were heated for 10 min, then immediately chilled prior to assay. Assays for total activity (Cm present) and thioesterase (Cm absent) wereperformed at two differentprotein levels. Results are expressed as percentages ofthe unheated activity: 6 mg ofprotein per ml, total (0) and thioesterase (U) activities; 0.6 mg ofprotein per ml, total (0) and thioesterase (0) activities. cific thioesterase activity (Fig. 2) . The sharp optimum at pH 7.8 for the B. fragilis CAT is identical to that reported for the enzymes produced by E. coli and staphylococci (17) .
(iii) Stability during storage. In contrast to the E. coli CAT (17), the enzymes produced by the B. fragilis strains were unstable to storage at -21°C: up to 40% of activity could be lost during overnight storage of crude extracts at -21°C. Storage at 40C was also unsatisfactory. During longer periods of storage, maximum activity was retained in preparations stored at -21°C in buffers of pH 6.6 to 7.6, with high protein concentrations.
(iv) Michaelis constant. Km determinations made for crude or partially purified extracts were similar and averaged 5.2 ,uM for the CAT produced by strain F48 (Fig. 3) . The Km for CAT from E. coli MB27 was 5.6 ,uM.
(v) Sensitivity to inhibitors. Preincubation of CAT from strain F48 with disodium ethylenediaminetetraacetic acid at concentrations up to 10 mM did not alter activity, whereas p-chloromercuribenzoate completely inhibited activity at 1 mM. Sensitivity to 1 mM DTNB was determined for crude extracts of B. fragilis F48 and E. coli MB27 (Fig. 4) . Both enzymes were sensitive to inhibition by DTNB, although the decrease in activity was not as rapid as for the enzymes described by Foster and Shaw (8 Attempted purification of CAT from B. fragilis F48. CAT activity from strain F48 was partially purified using the method of Shaw and Brodsky (19) , to the stage of the second ammonium sulfate precipitation. The enzyme was then dialyzed against TCM buffer and made up to a volume of 25 ml, in preparation for chromatography on diethylaminoethyl-Sephadex (Table  3 ). The procedure caused the nonspecific thioesterase activity to decrease from 60 to 4% of total activity, accompanying a loss of 95% of the original protein and an eightfold increase in specific activity of CAT. However, the major loss of activity (65%) occurred after heating in the presence of ammonium sulfate. The yield could be increased to -75% by desalting (Sephadex G-50) or by dialysis (18 h before heating. This yield is similar to that reported by Shaw for the E. coli enzyme (17) . Further purification of the B. fragilis enzyme was made difficult by the loss of activity during chromatography on DEAE-Sephadex. Although the activity could be bound and subsequently eluted by 0.19 to 0.20 M NaCl,-only 15 to 20% of activity applied was recovered, resulting in a net decrease in the specific activity of CAT. Gel filtration through Sephadex G-100 or G-200, following partial purification, resulted in four-to sixfold increases in specific activity, with up to 90% of total activity recovered. Gel filtration did not eliminate the residual thioesterase activity, which had a similar (but not identical) elution volume. The molecular weight of CAT was estimated to be 89,000 ± 3,000 by gel filtration on a calibrated Sephadex G-100.
DISCUSSION
The results reported here show that the CAT produced by resistant B. fragilis strains shares broad characteristics with this class of enzymes produced by other genera. The B. fragilis CAT 109 VOL. 14, 1978 yielding 81 ml of cell-free extract after centrifugation. Streptomycin sulfate was added to a final concentration of 1%, and the precipitate was discarded after centrifugation. Ammonium sulfate was added to 50% saturation, and the precipitate obtained after centrifugation was dissolved in 80 ml of TCM buffer. The extract was held at 720C for 10 min, cooled immediately, and centrifuged. The supernatant fluid was brought to 50% saturation with ammonium sulfate; the precipitate was dissolved in 10 ml of TCM buffer, then dialyzed for 18 h against 100 volumes of TCM buffer. The extract was made up to 25 ml in TCM buffer and applied to a diethylaminoethyl (DEAE)-Sephadex column (see text). The activity eluted at 0.19 to 0.2M NaCl.
is an acidic protein with an approximate molecular weight of 89,000 ± 3,000 and a pH optimum of 7.8. It is similar to the staphylococcal enzymes with respect to heat stability and Km but resembles the type II enzyme ofE. coli in its sensitivity to DTNB (8, 17) . Consequently, the enzyme is a new form of CAT and cannot be classified as one of the staphylococcal or E. coli enzyme types already described (17) . Further comparisons can only be made on the basis of the primary structure of the CAT protein and immunological reactions with antisera against other enzymes. Amino acid sequencing, N-terminal analysis, and large-fragment sequence determinations have shown that there is little homology between the staphylococcal and E. coli enzymes except for that at the active site (18) . The four variants of S. aureus CAT display a high degree of homology in primary structure, whereas the R-plasmid type I, II, and III enzymes show striking sequence differences. Protein analyses may reveal similarities between the primary structures of the B. fragilis enzyme and one of the above. However, such comparative studies are complicated by the relatively low specific activity and instability of the enzyme, so that difficulties may arise in obtaining enough purified enzyme. The cause of the observed instability has not been investigated here, but may be related to interaction of the enzyme with metabolites found in the Bacteroides extracts. In conjunction with this, maintenance of the tetrameric structure of the enzyme in this background may require the presence of stabilizing compounds, especially during and following the heating step in the purification procedure. Treatment of these strains with NTG failed to yield Cm-resistant mutants. If the CAT gene is not "native" to B. fragilis, it is apparent that it was introduced into the resistant strains from another species. The obvious candidate for donation of the genes is E. coli, in which resistance to-Cm is R-plasmid associated. The stool specimen from which the Cm-resistant B. fragilis strains were isolated also contained multiply resistant E. coli, with the Cm-tetracycline-resistant phenotype predominating. ity. Lower specific activity in the B. fragilis strain can be explained in terms of gene dosage, as there may be fewer CAT genes (plasmid copies) in the B. fragilis. Alternatively, integration of the genes into the chromosome may be causing suppression of enzyme production, as observed in E. coli (11) . This circumstantial evidence implies that the same CAT gene occurs in both species. An attractive hypothesis is that in vivo transfer of a plasmid-associated CAT gene occurred between the E. coli and B. fragilis strains. However, verifying the common origin of the CAT gene in the Cm-resistant strains has so far proven difficult. Although both the E. coli and B. fragilis strains host several plasmids (Britz and Wilkinson, unpublished data), the correlation between the plasmids and any markers remains elusive. One problem is the lack of a conjugational system in B. fragilis; transfer of R-plasmids into B. fragilis in vitro may be possible, but attempted transfer into other Bacteroides or E. coli strains was unsuccessful (4). In addition, there is some evidence that the Cm-tetracycline resistance occurring in E. coli is not directly transferable, which may be due to lack of transfer genes or a chromosomal location of the determinants (Britz and Wilkinson, unpublished data). The latter would not be expected, considering that both tetracycline and Cm resistance are associated with transposable elements (6) . Further efforts are currently being made to define the genetic determination of CAT production in B. fragilis.
